Source: Fox News
Summary
A study published in Clinical Nutrition found 15 cases of Wernicke encephalopathy, a brain disorder linked to vitamin B1 deficiency, in people taking GLP-1 weight-loss drugs like Ozempic and Wegovy. The cases were identified through the FDA’s Adverse Event Reporting System and medical literature. Researchers noted that most patients experienced gastrointestinal symptoms or malnutrition. While the study does not prove the medications caused the condition, experts say the risk is rare but real. They emphasized the importance of proper nutrition and hydration while using these drugs.
Our Reading
This guidance has been heard before.
Wernicke encephalopathy is rare but serious.
GLP-1 drugs are linked to nutritional deficiencies.
Experts say the risk is small but should not be ignored.
The advice sounds familiar, but the details change.
Author: Evan Null
